Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
- March -
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
- 2017 -
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
March 2017 - 106 products
IP
CI
Levetiracetam Stada 250 mg
30
PR
PR
k.A.
Coated tablets: Levetiracetamum 250 mg
Spirig HealthCare AG
B
FB
G
IP
Levetiracetam Stada 500 mg
20
PR
PR
k.A.
Coated tablets: Levetiracetamum 500 mg
Spirig HealthCare AG
B
FB
G
IP
Levetiracetam Stada 500 mg
100
PR
PR
k.A.
Coated tablets: Levetiracetamum 500 mg
Spirig HealthCare AG
B
FB
G
IP
Levetiracetam Stada 500 mg
200
PR
PR
k.A.
Coated tablets: Levetiracetamum 500 mg
Spirig HealthCare AG
B
FB
G
IP
Levetiracetam Stada 750 mg
100
PR
PR
k.A.
Coated tablets: Levetiracetamum 750 mg
Spirig HealthCare AG
B
FB
G
IP
Levetiracetam Stada 1000 mg
30
PR
PR
k.A.
Coated tablets: Levetiracetamum 1000 mg
Spirig HealthCare AG
B
FB
G
IP
Levetiracetam Stada 1000 mg
100
PR
PR
k.A.
Coated tablets: Levetiracetamum 1000 mg
Spirig HealthCare AG
B
FB
G
IP
Levetiracetam Stada 1000 mg
200
PR
PR
k.A.
Coated tablets: Levetiracetamum 1000 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Metoject Autoinjektor 7.5
mg/0.15 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 7.5mg / 0.15ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 10
mg/0.2 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 10mg / 0.2ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
12.5 mg/0.25 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 12.5mg / 0.25ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 15
mg/0.3 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 15mg / 0.3ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
17.5 mg/0.35 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 17.5mg / 0.35ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 20
mg/0.4 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 20mg / 0.4ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
22.5 mg/0.45 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 22.5mg / 0.45ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 25
mg/0.5 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 25mg / 0.5ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
27.5 mg/0.55 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 27.5mg / 0.55ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 30
mg/0.6 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 30mg / 0.6ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 7.5
mg/0.15 ml
4
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 7.5mg / 0.15ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 10
mg/0.2 ml
4
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 10mg / 0.2ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
12.5 mg/0.25 ml
4
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 12.5mg / 0.25ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 15
mg/0.3 ml
4
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 15mg / 0.3ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
17.5 mg/0.35 ml
4
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 17.5mg / 0.35ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 20
mg/0.4 ml
4
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 20mg / 0.4ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
22.5 mg/0.45 ml
4
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 22.5mg / 0.45ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 25
mg/0.5 ml
4
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 25mg / 0.5ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
27.5 mg/0.55 ml
4
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 27.5mg / 0.55ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 30
mg/0.6 ml
4
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 30mg / 0.6ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 7.5
mg/0.15 ml
6
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 7.5mg / 0.15ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 10
mg/0.2 ml
6
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 10mg / 0.2ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
12.5 mg/0.25 ml
6
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 12.5mg / 0.25ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 15
mg/0.3 ml
6
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 15mg / 0.3ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
17.5 mg/0.35 ml
6
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 17.5mg / 0.35ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 20
mg/0.4 ml
6
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 20mg / 0.4ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
22.5 mg/0.45 ml
6
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 22.5mg / 0.45ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 25
mg/0.5 ml
6
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 25mg / 0.5ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
27.5 mg/0.55 ml
6
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 27.5mg / 0.55ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 30
mg/0.6 ml
6
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 30mg / 0.6ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 7.5
mg/0.15 ml
12
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 7.5mg / 0.15ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 10
mg/0.2 ml
12
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 10mg / 0.2ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
12.5 mg/0.25 ml
12
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 12.5mg / 0.25ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 15
mg/0.3 ml
12
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 15mg / 0.3ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
17.5 mg/0.35 ml
12
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 17.5mg / 0.35ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 20
mg/0.4 ml
12
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 20mg / 0.4ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
22.5 mg/0.45 ml
12
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 22.5mg / 0.45ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 25
mg/0.5 ml
12
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 25mg / 0.5ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
27.5 mg/0.55 ml
12
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 27.5mg / 0.55ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 30
mg/0.6 ml
12
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 30mg / 0.6ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 7.5
mg/0.15 ml
24
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 7.5mg / 0.15ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 10
mg/0.2 ml
24
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 10mg / 0.2ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
12.5 mg/0.25 ml
24
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 12.5mg / 0.25ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 15
mg/0.3 ml
24
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 15mg / 0.3ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
17.5 mg/0.35 ml
24
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 17.5mg / 0.35ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 20
mg/0.4 ml
24
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 20mg / 0.4ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
22.5 mg/0.45 ml
24
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 22.5mg / 0.45ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 25
mg/0.5 ml
24
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 25mg / 0.5ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor
27.5 mg/0.55 ml
24
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 27.5mg / 0.55ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject Autoinjektor 30
mg/0.6 ml
24
PR
PR
k.A.
Injektionslösung im Fertigpen: Methotrexatum 30mg / 0.6ml
Gebro Pharma AG
A
FB
G
IP
CI
Domperidon lingual Spirig HC 10 mg
30
2.46
11.90
10 %
Melting tablets: Domperidonum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Domperidon lingual Spirig HC 10 mg
100
6.72
16.55
10 %
Melting tablets: Domperidonum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Oxycodon Naloxon Spirig HC 5
mg/2.5 mg
30
9.13
26.35
10 %
Delayed release tablets: 2 Active Agents
Spirig HealthCare AG
A+ / SL / SG
FB
G
IP
CI
Oxycodon Naloxon Spirig HC 5
mg/2.5 mg
60
16.06
33.90
10 %
Delayed release tablets: 2 Active Agents
Spirig HealthCare AG
A+ / SL / SG
FB
G
IP
Oxycodon Naloxon Spirig HC 10
mg/5 mg
30
13.94
31.60
10 %
Delayed release tablets: 2 Active Agents
Spirig HealthCare AG
● 
A+ / SL / SG
FB
G
IP
Oxycodon Naloxon Spirig HC 10
mg/5 mg
60
24.51
43.05
10 %
Delayed release tablets: 2 Active Agents
Spirig HealthCare AG
A+ / SL / SG
FB
G
IP
Oxycodon Naloxon Spirig HC 20
mg/10 mg
30
23.51
42.00
10 %
Delayed release tablets: 2 Active Agents
Spirig HealthCare AG
● 
A+ / SL / SG
FB
G
IP
Oxycodon Naloxon Spirig HC 20
mg/10 mg
60
44.94
65.30
10 %
Delayed release tablets: 2 Active Agents
Spirig HealthCare AG
A+ / SL / SG
FB
G
IP
Oxycodon Naloxon Spirig HC 40
mg/20 mg
30
43.53
63.75
10 %
Delayed release tablets: 2 Active Agents
Spirig HealthCare AG
● 
A+ / SL / SG
FB
G
IP
Oxycodon Naloxon Spirig HC 40
mg/20 mg
60
84.08
107.85
10 %
Delayed release tablets: 2 Active Agents
Spirig HealthCare AG
● 
A+ / SL / SG
FB
G
IP
CI
Bosentan-Mepha 62.5 mg
56
829.85
918.95
10 %
Coated tablets: Bosentanum 62.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Bosentan-Mepha 125 mg
56
829.85
918.95
10 %
Coated tablets: Bosentanum 125 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Co-Olmesartan Spirig HC 20
mg/12,5 mg
30
13.74
31.35
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Co-Olmesartan Spirig HC 20
mg/12,5 mg
100
40.86
60.80
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Co-Olmesartan Spirig HC 20
mg/25 mg
30
13.74
31.35
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Co-Olmesartan Spirig HC 20
mg/25 mg
100
40.86
60.80
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Co-Olmesartan Spirig HC 40
mg/12,5 mg
30
17.53
35.45
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Co-Olmesartan Spirig HC 40
mg/12,5 mg
100
52.13
73.05
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Co-Olmesartan Spirig HC 40
mg/25 mg
30
17.53
35.45
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Co-Olmesartan Spirig HC 40
mg/25 mg
100
52.13
73.05
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Emtricitabin-Tenofovir-
Mepha
30
42.33
72.00
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Emtricitabin-Tenofovir-
Mepha
30
42.33
72.00
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
● 
A / SL / SG
FB
G
IP
CI
Entecavir Sandoz 0.5 mg
30 + 30 + 30 + 30 + 30
355.06
402.55
10 %
Coated tablets: Entecavirum
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Entecavir Sandoz 1 mg
30 + 30 + 30 + 30 + 30
448.32
504.00
10 %
Coated tablets: Entecavirum 1 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Perindopril-Indapamid-
Mepha 10 mg / 2.5 mg
30
15.23
33.00
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Perindopril-Indapamid-
Mepha 10 mg / 2.5 mg
90
38.85
58.65
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Solifenacin-Mepha 5mg
30
17.90
35.90
10 %
Coated tablets: Solifenacini Succinas 5 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Solifenacin-Mepha 5mg
90
49.94
70.80
10 %
Coated tablets: Solifenacini Succinas 5 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Solifenacin-Mepha 5mg
100
55.49
76.50
10 %
Coated tablets: Solifenacini Succinas 5 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
Solifenacin-Mepha, 10mg
30
21.39
39.70
10 %
Coated tablets: Solifenacini Succinas 10 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
Solifenacin-Mepha, 10mg
90
59.69
81.40
10 %
Coated tablets: Solifenacini Succinas 10 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
Solifenacin-Mepha, 10mg
100
66.32
88.20
10 %
Coated tablets: Solifenacini Succinas 10 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Duloxetin-Mepha 30 mg
30
11.21
28.55
10 %
magensaftresistente Hartkapseln: Duloxetinum 30 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Duloxetin-Mepha 30 mg
100
31.75
50.80
10 %
magensaftresistente Hartkapseln: Duloxetinum 30 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Duloxetin-Mepha 30 mg
100
31.75
50.80
10 %
magensaftresistente Hartkapseln: Duloxetinum 30 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Duloxetin-Mepha 60 mg
10
6.94
24.10
10 %
magensaftresistente Hartkapseln: Duloxetinum 60 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Duloxetin-Mepha 60 mg
30
19.73
37.80
10 %
magensaftresistente Hartkapseln: Duloxetinum 60 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Duloxetin-Mepha 60 mg
90
54.71
75.90
10 %
magensaftresistente Hartkapseln: Duloxetinum 60 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Duloxetin-Mepha 60 mg
100
60.79
82.15
10 %
magensaftresistente Hartkapseln: Duloxetinum 60 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
PP
Glyxambi 10 mg / 5 mg
30
73.14
95.95
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
PP
Glyxambi 10 mg / 5 mg
90
216.89
252.30
10 %
Coated tablets: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
Oxycodon Naloxon Spirig HC 30
mg/15 mg
30
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Spirig HealthCare AG
A+
FB
G
IP
Oxycodon Naloxon Spirig HC 30
mg/15 mg
60
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Spirig HealthCare AG
A+
FB
G
IP
CI
Bosentan-Mepha 62.5 mg
14
PR
PR
k.A.
Coated tablets: Bosentanum 62.5 mg
Mepha Pharma AG
B
FB
G
IP
CI
Bosentan-Mepha 125 mg
14
PR
PR
k.A.
Coated tablets: Bosentanum 125 mg
Mepha Pharma AG
B
FB
G
IP
CI
Entecavir Sandoz 0.5 mg
30
PR
PR
k.A.
Coated tablets: Entecavirum
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Entecavir Sandoz 1 mg
30
PR
PR
k.A.
Coated tablets: Entecavirum 1 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
CM
Pantofelan
14
PR
PR
k.A.
magensaftresistente Filmtabletten: Pantoprazolum 20 mg
G-Pharma AG
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home